01—Abstract
Summary
Summary of the 8-K filed November 7, 2025. Cited figures are marked; the original filing is the authoritative source.
Exelixis, Inc. (EXEL) disclosed in this Form 8-K, filed November 7, 2025, that Jeffrey Hessekiel, J.D., Executive Vice President and General Counsel, notified the Company on November 4, 2025 of his intention to resign.
He will cease serving as General Counsel effective November 7, 2025, and his resignation is stated not to result from any disagreement with the Company. The Company also announced that Brenda Hefti, J.D., Ph.D., Senior Vice President, Intellectual Property (IP) & Licensing, will be promoted to General Counsel effective November 7, 2025. She will report to Michael Morrissey, Ph.D., President and Chief Executive Officer.
Dr. Hefti joined the Company in 2013 as corporate counsel, became Head of IP in 2014, and has served as Senior Vice President, IP & Licensing since 2020. For investors, the filing is a planned leadership transition within the legal function, with an internal successor already named and effective on the same date as the departure. The filing does not disclose any change to compensation arrangements or any other financial or operational terms.
02—Key points
Key Highlights
- Jeffrey Hessekiel, J.D., Executive Vice President and General Counsel, will cease serving as General Counsel effective November 7, 2025.
- Mr. Hessekiel's resignation was notified to the Company on November 4, 2025, and the filing states it was not the result of any disagreement with the Company.
- Brenda Hefti, J.D., Ph.D., Senior Vice President, Intellectual Property (IP) & Licensing, will be promoted to General Counsel effective November 7, 2025.
- Dr. Hefti will report to Michael Morrissey, Ph.D., President and Chief Executive Officer.
- Dr. Hefti joined Exelixis in 2013 as corporate counsel, was promoted to Head of IP in 2014, and has served as Senior Vice President, IP & Licensing since 2020.
- The filing discloses no changes to compensation arrangements for either officer.
03—Questions
Frequently Asked Questions
Why is the General Counsel leaving Exelixis?
The filing states that Mr. Hessekiel notified the Company of his intention to resign, effective in November 2025, and that his decision was not the result of any disagreement with the Company. It does not give further reasons.
Who is replacing the General Counsel?
Brenda Hefti, J.D., Ph.D., currently Senior Vice President, Intellectual Property & Licensing, will be promoted to General Counsel effective November 7, 2025.
What is Dr. Hefti's background at the Company?
Dr. Hefti joined Exelixis in 2013 as corporate counsel, was promoted to Head of IP in 2014, and has served as Senior Vice President, IP & Licensing since 2020.
To whom will the new General Counsel report?
Dr. Hefti will report to Michael Morrissey, Ph.D., President and Chief Executive Officer.
Does this filing include any financial results or changes to compensation?
No. The filing covers only the officer transition and states nothing about financial results, compensation arrangements, or guidance.
04—Continue